Tasigna 200 MG capsule 28S
Ended Awarded
- Contract number
- SPE2DB25FLWAQ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $6,008
Award facts
- Contract value 100% obligated
- $6,007.90 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Tasigna 200 mg capsules (28-count) under a firm fixed-price contract. The delivery order, valued at $6,007.90, was competitively awarded without set-aside restrictions and carries a completion date of October 8, 2025. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The prime contractor, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems.
This delivery order exemplifies AmerisourceBergen Drug Corp's extensive portfolio of pharmaceutical deliveries through the DLA Medical Supply Chain. The company's federal contract awards demonstrate its capability to fulfill a wide spectrum of medical product requirements, ranging from specialty medications and brand-name drugs to generics and medical supplies. The Tasigna 200 mg capsule delivery supports military healthcare programs as part of the company's established role as a primary pharmaceutical vendor for defense-related medical procurement. The non-set-aside competitive award underscores AmerisourceBergen Drug Corp's demonstrated capability to meet federal procurement standards in an open competition environment.
Quick answers
Who was awarded contract SPE2DB25FLWAQ?
SPE2DB25FLWAQ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 17, 2025.
How much is contract SPE2DB25FLWAQ worth?
The government has obligated $6,008 on SPE2DB25FLWAQ.
Is contract SPE2DB25FLWAQ an order under another contract?
Yes. SPE2DB25FLWAQ is a delivery order under SPE2DB22D6029, an indefinite delivery contract.
Was contract SPE2DB25FLWAQ competed?
The extent of competition for SPE2DB25FLWAQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award